Lobsor Pharmaceuticals is a privately held company based in Uppsala, Sweden founded late 2013. It is a fully owned subsidiary to Lobsor Holding AB. The founders of Lobsor, Ulf Rosén and Roger Bolsöy, have substantial previous experience from the treatment of Parkinson’s disease in advanced stages especially continuous infusion of levodopa into the small intestine via a pump. Based on their own experience, and in close liaison with leading neurologists and patient organizations expressing and formulating areas of therapy improvements, the Lecigon treatment system has been developed with the aim to, in several aspects, improve daily living for individuals affected by progressive Parkinson’s disease and suitable for an invasive treatment.